UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers (2019)
- Authors:
- USP affiliated authors: ROCHA, ADRIANA - FCFRP ; LANCHOTE, VERA LUCIA - FCFRP ; OLIVEIRA, RENÊ DONIZETI RIBEIRO DE - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1016/j.jchromb.2019.121712
- Subjects: PLASMA; FARMACOCINÉTICA; ESTUDOS DE VALIDAÇÃO; DISLIPIDEMIAS
- Keywords: Clinical study; Gemfibrozil; Human plasma; Pharmacokinetics; UPLC-MS/MS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Chromatography B
- ISSN: 1570-0232
- Volume/Número/Paginação/Ano: v. 1125, art. 121712, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CESTARI, Roberta Natália et al. UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers. Journal of Chromatography B, v. 1125, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2019.121712. Acesso em: 15 maio 2024. -
APA
Cestari, R. N., Rocha, A., Oliveira, R. D. R. de, & Lanchote, V. L. (2019). UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers. Journal of Chromatography B, 1125. doi:10.1016/j.jchromb.2019.121712 -
NLM
Cestari RN, Rocha A, Oliveira RDR de, Lanchote VL. UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers [Internet]. Journal of Chromatography B. 2019 ; 1125[citado 2024 maio 15 ] Available from: https://doi.org/10.1016/j.jchromb.2019.121712 -
Vancouver
Cestari RN, Rocha A, Oliveira RDR de, Lanchote VL. UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers [Internet]. Journal of Chromatography B. 2019 ; 1125[citado 2024 maio 15 ] Available from: https://doi.org/10.1016/j.jchromb.2019.121712 - Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose
- Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers
- Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers
- Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers
- Detection of allopurinol and oxypurinol in canine urine by HPLC/MS-MS: focus on veterinary clinical pharmacokinetics
- Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers
- Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients
- Clinical treatment for hepatitis C reverses CYP2C19 inhibition
- Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. [Carta]
- Enantiosseletividade na farmacocinética da fluvastatina em ratos espontaneamente hipertensos e/ou com diabetes mellitus experimental
Informações sobre o DOI: 10.1016/j.jchromb.2019.121712 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
